Table 3.
Sipuleucel-T | Docetaxel | |
---|---|---|
Treatment period | 1 month | 7 months |
Common adverse events | Fever and chills for 3 days | Hair loss |
Percentage of patients hospitalized for adverse events | 1.2% | >26% |
Percentage of patients stopping treatment because of adverse events | 1% | 11% |
Percentage of patients dying owing to adverse events | None | 1% to 3% |